>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
经导管肝动脉化学栓塞术联合无水乙醇注射治疗肝细胞性肝癌疗效分析
作者:李宏波 邱少敏 
单位:东南大学医学院附属南京第二医院B超室,江苏南京,210003
关键词:经导管肝动脉化学栓塞术 无水乙醇注射 肝细胞性肝癌 
分类号:R735.7, R815
出版年·卷·期(页码):2008·27·第五期(368-370)
摘要:

目的:对经导管肝动脉化学栓塞术(TACE)联合B超引导下肝脏瘤体内无水乙醇注射术(PEI)治疗肝细胞性肝癌进行疗效分析.方法:将50例肝癌患者随机分为两组,治疗组(24例)予TACE联合PEI治疗,对照组(26例)单用TACE治疗.结果:治疗组6、12、18个月生存率依次为83.33%、54.17%和33.33%,最长生存30个月以上;对照组仅5例生存达12个月以上,生存率为19.23%.经统计学处理有显著性差异(P<0.01).结论:TACE联合PEI是提高肝细胞性肝癌患者远期生存率较好的治疗方式.

Objective To observe the effect on the treatment of hepatocellular carcinoma by hepatic transcatheter arterial chemoembolization(TACE) combining with percutaneous ethanol injection(PEI).Methods Fifty patients with hepatocellular carcinoma,were randomly divided into two groups.Treatment group included 24 patients,who were treated with TACE+PEI,while control group included 26 patients,who were treated with TACE alone.Results The survival rates of six months,twelve months,eighteen months were 83.33%,54.16% and 33.33%,respectively in the treatment group,and the longest survival time was more than thirty months.In the control group only five patients existed above twelve months,with the survival rate of 19.23%.Significant differences were found between two groups(P&lt;0.01).Conclusion PEI combining with TACE can enhance the curative effect on hepatocellular carcinoma,which is a kind of valuable remedy for hepatocellular carcinoma to increase the long-term survival rate.

参考文献:

[1] 郭佳, 杨甲梅, 吴孟超. 超声介入无水酒精瘤内注射治疗肝癌的意义. 中国实用外科杂志2001(8)
[2] 林学英, 林礼务. 经皮超声介入无水酒精治疗肝癌及其疗效评估方法的进展. 临床超声医学杂志2003(5). doi:10.3969/j.issn.1008-6978.2003.05.013
[3] LIYERAGHI T, LAZZARONI S, MELONI F. Intralesional ethanol in the treatment of unresectable liver cancer. 2002. doi:10.1007/BF00299774
[4] 李玉亮, 赵斌, 王振亭. 肝细胞癌血管内栓塞治疗进展. 中国医学影像技术2002(3)
[5] 郭启勇. 介入放射学, 2000

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 417614 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364